Suggesting the cancer trials were cardiovascular tests is misleading and inappropriate, says Richard Milani , vice chairman of the department of cardiology at the OchsnerClinic in New Orleans.
Chip Lavie, a cardiologist at the OchsnerClinic in New Orleans, says that he would not worry about using Vioxx for short-term use, but understands Merck's decision to pull it.